Triflusal
Triflusal structure
|
Common Name | Triflusal | ||
|---|---|---|---|---|
| CAS Number | 322-79-2 | Molecular Weight | 248.155 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 316.0±42.0 °C at 760 mmHg | |
| Molecular Formula | C10H7F3O4 | Melting Point | 115 °C | |
| MSDS | Chinese USA | Flash Point | 144.9±27.9 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of TriflusalTriflusal irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1.Target: COXTriflusal at 10 mM, 100 mM and 1 M decreases LDH efflux in rat brain slices after anoxia/reoxygenation by 24%, 35% and 49% respectively. Triflusal also reduces inducible NO synthase activity by 18%, 21% and 30% [1].Triflusal (10 mg/kg i.v.) reduces platelet deposition on subendothelium-induced primary thrombus by about 68% in rabbits. Triflusal (10 mg/kg i.v.) reduces platelet deposition on a fresh thrombus formed over tunica media by about 48% in rabbits. Triflusal (40 mg/kg p.o.) reduces platelet deposition on a primary thrombus triggered by subendothelium and tunica media by 53% in rabbits. Triflusal (40 mg/kg p.o.) significantly reduces Cox-2 mRNA levels and protein levels without influence Cox-1 mRNA levels on the vascular wall in rabbits [2]. Triflusal (600 mg/day for 5 days) results in an increase in NO production by neutrophils and an increase in endothelial nitric oxide synthase (eNOS) protein expression in neutrophils in healthy volunteers [3]. |
This table lists Chinese names, IUPAC names and various aliases of this chemical substance.
| Name | 2-acetyloxy-4-(trifluoromethyl)benzoic acid |
|---|---|
| Synonym | More Synonyms |
This table contains bioactivity, target information and biological‑assay experimental data of this compound.
| Description | Triflusal irreversibly inhibits the production of thromboxane-B2 in platelets by acetylating cycloxygenase-1.Target: COXTriflusal at 10 mM, 100 mM and 1 M decreases LDH efflux in rat brain slices after anoxia/reoxygenation by 24%, 35% and 49% respectively. Triflusal also reduces inducible NO synthase activity by 18%, 21% and 30% [1].Triflusal (10 mg/kg i.v.) reduces platelet deposition on subendothelium-induced primary thrombus by about 68% in rabbits. Triflusal (10 mg/kg i.v.) reduces platelet deposition on a fresh thrombus formed over tunica media by about 48% in rabbits. Triflusal (40 mg/kg p.o.) reduces platelet deposition on a primary thrombus triggered by subendothelium and tunica media by 53% in rabbits. Triflusal (40 mg/kg p.o.) significantly reduces Cox-2 mRNA levels and protein levels without influence Cox-1 mRNA levels on the vascular wall in rabbits [2]. Triflusal (600 mg/day for 5 days) results in an increase in NO production by neutrophils and an increase in endothelial nitric oxide synthase (eNOS) protein expression in neutrophils in healthy volunteers [3]. |
|---|---|
| Related Catalog | |
| Target |
COX-2:280 μM (IC50) COX-2:160 μM (IC50, in human blood) |
| References |
This table shows physicochemical parameters including melting point, boiling point, density, solubility and optical rotation. Missing data is marked as N/A.
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 316.0±42.0 °C at 760 mmHg |
| Melting Point | 115 °C |
| Molecular Formula | C10H7F3O4 |
| Molecular Weight | 248.155 |
| Flash Point | 144.9±27.9 °C |
| Exact Mass | 248.029648 |
| PSA | 63.60000 |
| LogP | 2.90 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.484 |
| InChIKey | RMWVZGDJPAKBDE-UHFFFAOYSA-N |
| SMILES | CC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O |
| Storage condition | 2-8°C |
This table provides MSDS information including hazard classification, first‑aid, fire‑fighting, spill handling, operation and storage instructions.
This table summarizes toxicological test data, acute & chronic toxicity and ecological hazard parameters for this chemical.
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
This table covers safety warnings, protective measures, incompatible substances and disposal guidelines for this compound.
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H317-H319-H335 |
| Precautionary Statements | P261-P280-P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Phrases | 22-36/37/38-43 |
| Safety Phrases | 26-36/37 |
| RIDADR | NONH for all modes of transport |
| RTECS | GP4250000 |
| HS Code | 2918990090 |
This table presents publicly reported synthetic routes, reaction conditions, reactants and product information of the compound.
|
~%
Triflusal CAS#:322-79-2 |
| Literature: Journal of the American Chemical Society, , vol. 76, p. 1051,1054 |
|
~%
Triflusal CAS#:322-79-2 |
| Literature: Journal of the American Chemical Society, , vol. 76, p. 1051,1054 |
This table lists upstream starting materials and downstream derivative products related to this chemical.
| Precursor 3 | |
|---|---|
| DownStream 1 | |
This table shows customs‑related data including HS‑code, tariff and regulatory conditions for import and export.
| HS Code | 2918990090 |
|---|---|
| Summary | 2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
This table lists relevant public references with title, journal and publication metadata for this compound.
|
Long-term follow-up of atrial fibrillation patients in the NASPEAF study. Prospective evaluation of different antiplatelet treatments.
Rev. Esp. Cardiol. 62(9) , 992-1000, (2009) In the NASPEAF (National Study for Prevention of Embolism in Atrial Fibrillation) trial, combination therapy with an anticoagulant and an antiplatelet was more effective than anticoagulation alone in ... |
|
|
Electrochemical behavior of triflusal, aspirin and their metabolites at glassy carbon and boron doped diamond electrodes.
Comb. Chem. High Throughput Screen 13(7) , 569-77, (2010) The electrochemical behavior of triflusal (TRF) and aspirin (ASA), before and after hydrolysis in water and in alkaline medium using two different electrode surfaces, glassy carbon and boron doped dia... |
|
|
A phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new enteric-coated triflusal formulations in healthy male volunteers.
Expert Opin. Drug Metab. Toxicol. 7(12) , 1471-9, (2011) An enteric-coated formulation of triflusal (triflusal EC), an antiplatelet agent, was developed to reduce the high incidence of gastrointestinal adverse events (AEs). The aim of this study is to compa... |
This table contains target information, in‑vitro & in‑vivo assay data for this compound.
This table collects all English aliases, systematic names and CAS‑related synonyms of the compound.
| Triflusal |
| 2-(acetyloxy)-4-(trifluoromethyl)benzoic acid |
| α,α,α-Trifluoro-2,4-cresotic Acid Acetate |
| 2-Acetoxy-4-trifluoromethylbenzoic acid |
| EINECS 206-297-5 |
| Triflusalum [INN-Latin] |
| 2-Acetoxy-4-trifluoromethylbenzoicacid |
| Triflusal [INN] |
| 2-Acetoxy-4-trifluormethyl-benzoesaeure |
| 2-Acetoxy-4-(trifluoromethyl)benzoic acid |
| 2-Acetyloxy-4-trifluoromethylbenzoic acid |
| UR 1501 |
| MFCD00866793 |
| Disgren |
| Triflux |
This section contains frequently‑asked‑questions about this compound, including basic parameters, properties, storage conditions and corresponding answers.
| Q: What is the melting point of 2-acetyloxy-4-(trifluoromethyl)benzoic acid? |
| A: Melting point of 2-acetyloxy-4-(trifluoromethyl)benzoic acid is 115 °C. |
| Q: What is the SMILES notation of 2-acetyloxy-4-(trifluoromethyl)benzoic acid? |
| A: SMILES notation of 2-acetyloxy-4-(trifluoromethyl)benzoic acid is CC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O. |
| Q: What is the LogP of 2-acetyloxy-4-(trifluoromethyl)benzoic acid? |
| A: LogP of 2-acetyloxy-4-(trifluoromethyl)benzoic acid is 2.90. |
| Q: What is the InChIKey of 2-acetyloxy-4-(trifluoromethyl)benzoic acid? |
| A: InChIKey of 2-acetyloxy-4-(trifluoromethyl)benzoic acid is RMWVZGDJPAKBDE-UHFFFAOYSA-N. |
| Q: What is the molecular weight of 2-acetyloxy-4-(trifluoromethyl)benzoic acid? |
| A: Molecular weight of 2-acetyloxy-4-(trifluoromethyl)benzoic acid is 248.155. |
| Q: What is the CAS number of 2-acetyloxy-4-(trifluoromethyl)benzoic acid? |
| A: CAS number of 2-acetyloxy-4-(trifluoromethyl)benzoic acid is 322-79-2. |
| Q: What are the downstream products of 2-acetyloxy-4-(trifluoromethyl)benzoic acid? |
| A: Related downstream products(CAS) of 2-acetyloxy-4-(trifluoromethyl)benzoic acid: 328-90-5. |
| Q: What is the safety information for 2-acetyloxy-4-(trifluoromethyl)benzoic acid? |
| A: Safety information for 2-acetyloxy-4-(trifluoromethyl)benzoic acid: 26-36/37. |
| Q: What English synonyms does 2-acetyloxy-4-(trifluoromethyl)benzoic acid have? |
| A: English synonyms of 2-acetyloxy-4-(trifluoromethyl)benzoic acid: Triflusal, 2-(acetyloxy)-4-(trifluoromethyl)benzoic acid, α,α,α-Trifluoro-2,4-cresotic Acid Acetate, 2-Acetoxy-4-trifluoromethylbenzoic acid, EINECS 206-297-5, Triflusalum [INN-Latin], 2-Acetoxy-4-trifluoromethylbenzoicacid, Triflusal [INN], 2-Acetoxy-4-trifluormethyl-benzoesaeure, 2-Acetoxy-4-(trifluoromethyl)benzoic acid, 2-Acetyloxy-4-trifluoromethylbenzoic acid, UR 1501, MFCD00866793, Disgren, Triflux. |
| Q: What is the polar surface area (PSA) of 2-acetyloxy-4-(trifluoromethyl)benzoic acid? |
| A: Polar surface area (PSA) of 2-acetyloxy-4-(trifluoromethyl)benzoic acid is 63.60000. |
This table lists manufacturers and suppliers of this compound, including vendor names and product supply reference information.
| Shanghai Nianxing Industrial Co., Ltd |